The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the increasing demand for personalized medicines, expansion in clinical research ...

The global eClinical solutions market is expected to grow at a CAGR of ~14% in the next five years. The growing complexity of clinical trials, rising adoption of decentralized clinical trials, a surge ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

A new study published in the Journal of American Medical Association showed that preoperative stereotactic radiotherapy (SRT) ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Gurathin never entered Murderbot looking for connection. He appeared as a living audit, a scanner in human form, a presence designed to provoke discomfort and force exposure.

In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

The global digital biomarkers market size was valued at USD 4.15 billion in 2024 and is predicted to hit around USD 32.37 ...

Implementing AI in healthcare isn’t just about choosing the right tools—it’s about making them work in the real world.

Of the 16 available MDD prediction instruments, researchers recommend using those assessing prior treatments and clinical characteristics.

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.